Your browser doesn't support javascript.
loading
Effectiveness of acceptance and commitment therapy for inpatients with psychosis: Implementation feasibility and acceptability from a pilot randomized controlled trial.
Gaudiano, Brandon A; Ellenberg, Stacy; Johnson, Jennifer E; Mueser, Kim T; Miller, Ivan W.
Afiliación
  • Gaudiano BA; Alpert Medical School of Brown University, United States of America; Butler Hospital, United States of America; Providence VA Medical Center, United States of America. Electronic address: Brandon_Gaudiano@brown.edu.
  • Ellenberg S; SUNY Upstate Medical Center, United States of America.
  • Johnson JE; Michigan State University, United States of America.
  • Mueser KT; Boston University, United States of America.
  • Miller IW; Alpert Medical School of Brown University, United States of America; Butler Hospital, United States of America.
Schizophr Res ; 261: 72-79, 2023 11.
Article en En | MEDLINE | ID: mdl-37716204
OBJECTIVE: Acceptance and Commitment Therapy for Inpatients (ACT-IN) with psychosis has been found to be efficacious in previous trials, but its effectiveness has not been studied when implemented by frontline clinicians in routine settings. METHOD: In this pilot randomized controlled effectiveness trial, inpatients with schizophrenia-spectrum disorders were randomized to ACT-IN plus treatment as usual (TAU) (n = 23) or a time/attention matched (TAM) supportive condition plus TAU (n = 23) delivered by routine hospital staff. Both conditions received individual and group therapy during inpatient care and completed follow-up phone sessions during the first month post-discharge. Patients were assessed through 4 months post-discharge (blinded to condition) to determine feasibility, acceptability, and preliminary effectiveness of ACT-IN. RESULTS: ACT-IN was feasible to deliver with fidelity by frontline staff when integrated into an acute care setting. At post-treatment, patients reported significantly greater treatment satisfaction in ACT-IN relative to TAM. Overall, results showed significant but similar improvements for both conditions through 4-month follow-up in psychiatric symptoms, functioning, and mindfulness. Only ACT-IN improved over time in distress. Furthermore, patients receiving TAM had a 3.76 times greater risk of rehospitalization over 4 months compared with ACT-IN. CONCLUSIONS: ACT-IN is feasible and acceptable for patients with psychosis, can be implemented by hospital staff when integrated into acute treatment, and may result in decreased rehospitalization compared to alternative therapies. A future full-scale randomized-controlled implementation trial is warranted. CLINICALTRIALS: gov Identifer: NCT02336581.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Terapia de Aceptación y Compromiso Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Schizophr Res Asunto de la revista: PSIQUIATRIA Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Terapia de Aceptación y Compromiso Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Schizophr Res Asunto de la revista: PSIQUIATRIA Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos